More Articles

Patients and Medical

How To Trust In The Age Of (Dis)Information

Lucy Fulford, (Oct 30, 2018)

Amid the smoke and mirrors, pharma has an opportunity to set the record straight.
Patients and Medical

I Made An App To Plug A Knowledge Gap

Lucy Fulford, (Oct 24, 2018)

Hellen Marguerite Juul struggled to find information on how to navigate a pregnancy with diabetes, so she came up with her own solution.
Access and Evidence

American Healthcare System 1 - 0 Europe

Andrew Stone, (Oct 23, 2018)

When it comes to pricing and access, the European healthcare system is losing.
Access and Evidence

Working with HTAs: It’s Your Move

Ross Davies, (Oct 16, 2018)

European HTA bodies have signaled that they want greater and earlier dialogue with pharma but is their call being answered?
Access and Evidence

Value: A Balancing Act

Ross Davies, (Oct 16, 2018)

When it comes to proving the value of a new medicine, pharma has to strike the right balance
Access and Evidence

Can Payers Trust Our Data?

Andrew Stone, (Oct 16, 2018)

Analyses from RWD are playing an increasingly important role, but will payers accept pharma’s figures?
Access and Evidence

Diving for Data

Andrew Stone, (Oct 16, 2018)

Finding the right data to underpin outcome-based contracts is not as easy as it looks
Access and Evidence

Rid Yourself Of Dirty Data

Andrew Stone, (Oct 11, 2018)

Real-world data holds enormous potential. But it also risks being riddled with bias.
Patients and Medical

The Discovery That Changed My Life

Lucy Fulford, (Oct 8, 2018)

For Rocco Falchetto, stepping into the sun was extremely painful. Then one day, everything changed.
Patients and Medical

Patients: The New Architects Of Clinical Trials?

Danielle Barron, (Oct 4, 2018)

The industry has long flirted with the idea of getting patients to design clinical trials. But is the idea coming to fruition?

Pages